Curis Inc cash flow statement
In fiscal 2025, Curis Inc's operations generated −$27.2m of cash; it spent $0 on capital projects, leaving free cash flow of −$27.2m.
Cash flow statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −8 | −2 | −5 | −15 | −10 | −17 | −30 | −36 | −48 | −30 | −26 | −26 | −38 | −54 | −38 | −40 | −27 | −31 |
| Depreciation and amortisation | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based pay | 2 | 2 | 2 | 4 | 3 | 3 | 4 | 4 | 5 | 4 | 3 | 3 | 5 | 7 | 6 | 6 | 4 | 3 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −8 | −2 | −5 | −15 | −10 | −17 | −30 | −36 | −49 | −30 | −26 | −26 | −38 | −55 | −38 | −40 | −27 | −31 |
| Free cash flow after stock pay | −9 | −4 | −7 | −19 | −13 | −20 | −34 | −40 | −54 | −34 | −29 | −29 | −43 | −62 | −44 | −45 | −31 | −33 |
| Shares issued | 4 | 2 | 2 | 5 | 16 | 0 | 65 | 0 | 42 | 0 | 0 | 159 | 0 | 6 | 14 | 12 | 15 | 25 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −6 | −9 | −7 | −8 | −6 | −6 | −9 | −10 |
| Depreciation and amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based pay | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −6 | −9 | −7 | −8 | −6 | −6 | −9 | −10 |
| Free cash flow after stock pay | −7 | −11 | −8 | −9 | −6 | −7 | −10 | −10 |
| Shares issued | 1 | 11 | 10 | −1 | 6 | −0 | 19 | −0 |
Compare with peers
- Camp4 Therapeutics Corp cash flow
- Ensysce Biosciences, Inc. cash flow
- Ocugen, Inc. cash flow
- Entrada Therapeutics, Inc. cash flow
- Bolt Biotherapeutics, Inc. cash flow
Head to head: CAMP vs CRISCRIS vs ENSCCRIS vs OCGN
More: Biotechnology stocks compared, Health Care sector, rankings of US companies